Enrollment completed for RE-DUAL PCI study of 2,700 atrial fibrillation patients
The Baim Institute has announced that patient enrollment into the international Phase IIIb RE-DUAL PCI study is complete. The study evaluates the safety and efficacy of dabigatran etexilate in atrial fibrillation (AF) patients ...
Nov 14, 2016
0
0